What is ZTS stock price today?

Visit our real-time dashboard for the current ZTS stock price and live market data.

Is ZTS stock going up or down today?

ZTS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ZTS stock now?

The decision to buy ZTS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ZTS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ZTS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ZTS stock overvalued or undervalued?

ZTS currently trades at a P/E ratio of 24.90 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ZTS is fairly priced.

What is ZTS's P/E ratio?

ZTS has a price-to-earnings (P/E) ratio of 24.90, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ZTS's market cap?

ZTS (Zoetis Inc) has a market capitalization of $64.65 billion, making it a mid-cap stock.

What is ZTS's price to book ratio?

Price-to-book ratio for ZTS is available on our dashboard along with other valuation metrics.

Does ZTS pay dividends?

Yes, ZTS pays dividends with a current yield of 1.28%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is ZTS's dividend yield?

ZTS's dividend yield is 1.28%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is ZTS stock a good long-term investment?

ZTS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ZTS's revenue growth rate?

Revenue growth data for ZTS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ZTS are available on our dashboard with complete income statement analysis.

What are the risks of investing in ZTS?

Key risks for ZTS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ZTS compare to its competitors?

Compare ZTS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ZTS's performance and positioning.

What is ZTS's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ZTS with bull, base, and bear case scenarios.

What do analysts say about ZTS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ZTS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ZTS's next earnings report?

ZTS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ZTS - Zoetis Inc

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About Zoetis Inc

Zoetis Inc (ZTS) common stock

Price Chart

Loading chart...

ZTS Key Statistics

Market Cap

$64.65B

P/E Ratio

24.90

Dividend Yield

1.28%

How ZTS Compares to Peers

ZTS is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ZTS(This stock)	$64.65B	24.9	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 14, 2026 at 1:26 AM EDT

Ready to invest in ZTS?

Commission-free trading available. Affiliate links.

ZTS Lician Score

10% confidence

5.0/10

Neutral

ZTS has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ZTSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ZTS Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ZTS

Dashboard

Enter a ticker to analyze